Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets closed
Straits Times Index
3,292.93
-3.96
(-0.12%)
Nikkei
38,236.07
-37.98
(-0.10%)
Hang Seng
18,475.92
+268.79
(+1.48%)
FTSE 100
8,213.49
+41.34
(+0.51%)
Bitcoin USD
63,700.43
+1,812.94
(+2.93%)
CMC Crypto 200
1,359.39
+82.41
(+6.45%)
Sihuan Pharmaceutical Holdings Group Ltd. (SHPHF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0575
0.0000
(0.00%)
At close: 01:37PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,860,539
1,860,539
2,181,189
3,038,391
2,464,226
Cost of revenue
564,895
564,895
693,608
607,903
549,777
Gross profit
1,295,644
1,295,644
1,487,581
2,430,488
1,914,449
Operating expenses
Research development
577,656
577,656
936,581
868,069
729,157
Selling general and administrative
911,215
911,215
1,023,336
1,128,958
858,576
Total operating expenses
1,487,129
1,487,129
2,041,789
1,782,809
1,465,582
Operating income or loss
-191,485
-191,485
-554,208
647,679
448,867
Interest expense
269,337
269,337
211,176
117,351
8,217
Income before tax
-161,260
-161,260
-2,122,778
496,013
765,844
Income tax expense
96,427
96,427
196,794
253,119
219,040
Income from continuing operations
-257,687
-257,687
-2,319,572
242,894
546,804
Net income
-54,017
-54,017
-1,914,918
416,509
473,382
Net income available to common shareholders
-54,017
-54,017
-1,914,918
416,509
473,382
Basic EPS
-0.21
-
-0.21
0.04
0.05
Diluted EPS
-0.21
-
-0.21
0.04
0.05
Basic average shares
9,321,505
-
9,329,999
9,431,297
9,465,682
Diluted average shares
9,321,505
-
9,336,768
9,487,677
9,465,682
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.